SB-300, Jaguar's Drug Product Candidate for the Treatment of Gastric Ulcers, Enables Continued Therapy in Performance Horses in Accordance with Standard Testing Guidelines

Results of Initial Study Show that Jaguar's Equine Product Candidate for Treatment of Gastric Ulcers May Offer Horse Owners an Additional Advantage in the Competition Horse World, where Requirements Exist for Animals to Compete Free from the Effect of Any Drugs

Issue 120 house ad

Thursday

April 25, 2019

Friday

April 26, 2019

Monday

April 29, 2019

Tuesday

April 30, 2019

Wednesday

May 1, 2019

Sign up for our free eNews letter. We do not share our list and we send one per week. Select any of the topics below.